These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19762093)

  • 1. Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease.
    Polosa R; Blackburn MR
    Trends Pharmacol Sci; 2009 Oct; 30(10):528-35. PubMed ID: 19762093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adenosine receptors in the treatment of asthma and chronic obstructive pulmonary disease: recent developments.
    van den Berge M; Hylkema MN; Versluis M; Postma DS
    Drugs R D; 2007; 8(1):13-23. PubMed ID: 17249846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine signaling in asthma and chronic obstructive pulmonary disease.
    Mohsenin A; Blackburn MR
    Curr Opin Pulm Med; 2006 Jan; 12(1):54-9. PubMed ID: 16357580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammation.
    Polosa R; Holgate ST
    Curr Drug Targets; 2006 Jun; 7(6):699-706. PubMed ID: 16787172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease.
    Polosa R
    Eur Respir J; 2002 Aug; 20(2):488-96. PubMed ID: 12212985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting adenosine receptors: novel therapeutic targets in asthma and chronic obstructive pulmonary disease.
    Rorke S; Holgate ST
    Am J Respir Med; 2002; 1(2):99-105. PubMed ID: 14720064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease.
    Prenner BM; Bukofzer S; Behm S; Feaheny K; McNutt BE
    J Nucl Cardiol; 2012 Aug; 19(4):681-92. PubMed ID: 22484721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine signaling and the regulation of chronic lung disease.
    Zhou Y; Schneider DJ; Blackburn MR
    Pharmacol Ther; 2009 Jul; 123(1):105-16. PubMed ID: 19426761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
    Zhou Y; Murthy JN; Zeng D; Belardinelli L; Blackburn MR
    PLoS One; 2010 Feb; 5(2):e9224. PubMed ID: 20169073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finding better therapeutic targets for patients with asthma: adenosine receptors?
    Polosa R
    Br J Pharmacol; 2008 Oct; 155(4):441-3. PubMed ID: 18852692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine receptors and asthma in humans.
    Wilson CN
    Br J Pharmacol; 2008 Oct; 155(4):475-86. PubMed ID: 18852693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine and adenosine receptors: their contribution to airway inflammation and therapeutic potential in asthma.
    Caruso M; Varani K; Tringali G; Polosa R
    Curr Med Chem; 2009; 16(29):3875-85. PubMed ID: 19747135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs.
    Akkari R; Burbiel JC; Hockemeyer J; Müller CE
    Curr Top Med Chem; 2006; 6(13):1375-99. PubMed ID: 16918456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutions.
    Trevethick MA; Mantell SJ; Stuart EF; Barnard A; Wright KN; Yeadon M
    Br J Pharmacol; 2008 Oct; 155(4):463-74. PubMed ID: 18846036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research and development of bronchodilators for asthma and COPD with a focus on G protein/KCa channel linkage and β2-adrenergic intrinsic efficacy.
    Kume H; Fukunaga K; Oguma T
    Pharmacol Ther; 2015 Dec; 156():75-89. PubMed ID: 26432616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future.
    Borah P; Deka S; Mailavaram RP; Deb PK
    Curr Pharm Des; 2019; 25(26):2792-2807. PubMed ID: 31333097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in the development of kinase inhibitors for treating asthma and COPD.
    McClean N; Hasday JD; Shapiro P
    Adv Pharmacol; 2023; 98():145-178. PubMed ID: 37524486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine receptors and asthma.
    Brown RA; Spina D; Page CP
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S446-56. PubMed ID: 18311158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of overlapping asthma-chronic obstructive pulmonary disease: Can guidelines contribute in an evidence-free zone?
    Reddel HK
    J Allergy Clin Immunol; 2015 Sep; 136(3):546-52. PubMed ID: 26343938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome.
    Nakawah MO; Hawkins C; Barbandi F
    J Am Board Fam Med; 2013; 26(4):470-7. PubMed ID: 23833163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.